1245.48.45003 Boehringer Ingelheim Investigational Site

København NV

0 studies enrolling now · 1 studies all time

What they study most

Diabetes Mellitus, Type 2, Hypertension

Studies at this site

• 12 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Patients With Type 2 Diabetes Mellitus — Completed